- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有69家主力机构披露2025-06-30报告期持股数据，持仓量总计9803.77万股，占流通A股17.42%
- 波段诊断：
-
技术面诊股
诊断结果：4.4技术面打败了38%的股票
技术面评分前10的股票
近期的平均成本为15.58元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为15.58元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.58","date":1765181505,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.12.09","stock":"-1.47","trade":null,"ind":"-0.39"},{"date":"2025.12.08","stock":"0.45","trade":null,"ind":"1.39"},{"date":"2025.12.05","stock":"1.49","trade":null,"ind":"1.08"},{"date":"2025.12.04","stock":"-1.35","trade":null,"ind":"0.40"},{"date":"2025.12.03","stock":"0.13","trade":null,"ind":"-0.78"},{"date":"2025.12.02","stock":"-1.52","trade":null,"ind":"-0.68"},{"date":"2025.12.01","stock":"-0.63","trade":null,"ind":"1.25"},{"date":"2025.11.28","stock":"0.25","trade":null,"ind":"0.85"},{"date":"2025.11.27","stock":"-1.55","trade":null,"ind":"-0.25"},{"date":"2025.11.26","stock":"2.35","trade":null,"ind":"1.02"},{"date":"2025.11.25","stock":"0.38","trade":null,"ind":"1.53"},{"date":"2025.11.24","stock":"-0.19","trade":null,"ind":"0.37"},{"date":"2025.11.21","stock":"-4.14","trade":null,"ind":"-3.41"},{"date":"2025.11.20","stock":"-2.84","trade":null,"ind":"-0.76"},{"date":"2025.11.19","stock":"-4.14","trade":null,"ind":"-0.00"},{"date":"2025.11.18","stock":"-1.34","trade":null,"ind":"-0.92"},{"date":"2025.11.17","stock":"-1.87","trade":null,"ind":"-0.11"},{"date":"2025.11.14","stock":"6.93","trade":null,"ind":"-1.93"},{"date":"2025.11.13","stock":"1.79","trade":null,"ind":"1.78"},{"date":"2025.11.12","stock":"0.36","trade":null,"ind":"-0.36"},{"date":"2025.11.11","stock":"-1.94","trade":null,"ind":"-1.03"}]
东富龙,深证成指,医疗器械指数
压力支撑
该股压力位为15.56元，支撑位为15.40元。
[{"text":"\u538b\u529b\u4f4d","value":"15.56","date":1765209600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.40","date":1765209600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了70%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月09日 20:30
| 机构今日流向(万元) | -954.95 | 机构5日流向(万元) | -1903.33 |
| 机构10日流向(万元) | -4524.30 | 机构20日流向(万元) | -11711.05 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少8.91万股，其中基金净减仓9家，主力净增仓13家，暂未发现中长期投资价值。
截止2025-06-30，共69家主力机构（一般法人6家，基金63家），持仓量总计9803.77万股，占流通A股17.42%
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 149.68万股
减仓：18家 ，减持 53.38万股
新出现在主力名单中：29家 ，持有84.75万股
从主力名单中消失：16家 ，原持有70.74万股
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 149.68万股
减仓：18家 ，减持 53.38万股
新出现在主力名单中：29家 ，持有84.75万股
从主力名单中消失：16家 ，原持有70.74万股
消息面诊股
诊断结果：5.9消息面打败了30%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东富龙：12月8日获融资买入908.08万元
2025-12-09 - 券商观点|医药生物行业周报：“医保&商保双目录”正
2025-12-08 - 东富龙：12月5日获融资买入792.15万元
2025-12-08 - 东富龙解锁布地奈德肠溶胶囊生产新范式
2025-12-05 - 【东东工艺指南】HPV疫苗生产纯化解决方案
2025-12-05 - 东富龙：12月4日获融资买入800.21万元
2025-12-05 - 东富龙：双方将继续发挥各自的技术优势，共同推动智慧
2025-12-03 - 东富龙：12月2日获融资买入835.83万元
2025-12-03 - 东富龙：12月1日获融资买入1120.92万元
2025-12-02 - 券商观点|医药生物行业周报：短期把握流感驱动，长期
2025-12-01
消息列表
| 一般消息 | 募资投向 | 2025-09-19 | |
| 一般消息 | 高管变动 | 因《公司章程》等内部制度调整 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2025-08-28 |
| 一般消息 | 高管变动 | 增强公司可持续发展能力 | 2025-08-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派0.76元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了47%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.12.09","price":"-0.39","value":null},{"date":"2025.12.08","price":"1.39","value":null},{"date":"2025.12.05","price":"1.08","value":null},{"date":"2025.12.04","price":"0.40","value":null},{"date":"2025.12.03","price":"-0.78","value":null},{"date":"2025.12.02","price":"-0.68","value":null},{"date":"2025.12.01","price":"1.25","value":null},{"date":"2025.11.28","price":"0.85","value":null},{"date":"2025.11.27","price":"-0.25","value":null},{"date":"2025.11.26","price":"1.02","value":null},{"date":"2025.11.25","price":"1.53","value":null},{"date":"2025.11.24","price":"0.37","value":null},{"date":"2025.11.21","price":"-3.41","value":null},{"date":"2025.11.20","price":"-0.76","value":null},{"date":"2025.11.19","price":"-0.00","value":null},{"date":"2025.11.18","price":"-0.92","value":null},{"date":"2025.11.17","price":"-0.11","value":null},{"date":"2025.11.14","price":"-1.93","value":null},{"date":"2025.11.13","price":"1.78","value":null},{"date":"2025.11.12","price":"-0.36","value":null},{"date":"2025.11.11","price":"-1.03","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 29.10% | 2.24% | 5.4分 |
| 2 | 中红医疗 | 13.72% | 3.84% | 5.0分 |
| 3 | 浩欧博 | 10.39% | -6.95% | 5.1分 |
| 4 | 康众医疗 | 10.37% | 2.90% | 4.9分 |
| 5 | 华兰股份 | 10.35% | 2.56% | 4.9分 |
| 6 | 国发股份 | 9.67% | 1.70% | 5.1分 |
| 8 | 中源协和 | 4.11% | -4.61% | 4.6分 |
| 10 | 佰仁医疗 | 2.30% | -6.73% | 4.3分 |
| 12 | 天臣医疗 | 1.16% | 7.01% | 5.5分 |
| 14 | 正海生物 | 0.38% | -6.06% | 4.2分 |
| 16 | 海利生物 | -0.43% | 3.09% | 5.1分 |
| 18 | 万东医疗 | -1.00% | -3.30% | 4.4分 |
| 20 | 鱼跃医疗 | -1.85% | -0.56% | 5.2分 |
| 22 | 乐心医疗 | -1.93% | 0.42% | 5.2分 |
| 24 | 大博医疗 | -1.97% | -1.63% | 4.8分 |
| 26 | 麦克奥迪 | -2.18% | 5.21% | 5.7分 |
| 28 | 黄山胶囊 | -2.66% | -0.98% | 5.1分 |
| 30 | 健帆生物 | -3.38% | -1.04% | 4.1分 |
| 32 | 健尔康 | -3.57% | -3.19% | 4.4分 |
| 34 | 爱迪特 | -3.75% | 0.02% | 4.8分 |
| 36 | 迈瑞医疗 | -4.17% | -0.95% | 4.7分 |
| 38 | 威高骨科 | -4.36% | -0.83% | 3.8分 |
| 40 | 威高血净 | -4.58% | -0.05% | 5.5分 |
| 42 | 美康生物 | -4.85% | -2.20% | 3.4分 |
| 44 | 济高发展 | -4.89% | -4.89% | 4.2分 |
| 46 | 华大智造 | -4.99% | -2.29% | 4.0分 |
| 48 | 维力医疗 | -5.23% | -0.37% | 5.0分 |
| 50 | 赛科希德 | -5.38% | -0.65% | 3.7分 |
| 52 | 山东药玻 | -5.58% | 0.20% | 4.6分 |
| 54 | 尚荣医疗 | -5.65% | -2.78% | 4.8分 |
| 56 | 万孚生物 | -5.70% | -0.29% | 4.2分 |
| 58 | 迈克生物 | -5.81% | -1.39% | 3.9分 |
| 60 | 爱朋医疗 | -5.92% | -2.77% | 4.3分 |
| 62 | 天益医疗 | -6.04% | -3.42% | 4.0分 |
| 64 | 艾德生物 | -6.11% | 2.00% | 4.4分 |
| 66 | 微电生理 | -6.40% | -3.22% | 3.4分 |
| 68 | 之江生物 | -6.45% | -2.75% | 3.4分 |
| 70 | 科华生物 | -6.57% | -4.90% | 3.8分 |
| 72 | 九安医疗 | -6.80% | -1.84% | 4.0分 |
| 74 | 亚辉龙 | -7.17% | -1.86% | 3.8分 |
| 76 | 戴维医疗 | -7.36% | -3.68% | 4.0分 |
| 78 | 海泰新光 | -7.47% | -0.45% | 4.6分 |
| 80 | 康泰医学 | -7.56% | -2.67% | 3.5分 |
| 82 | 康德莱 | -7.75% | -0.23% | 4.7分 |
| 84 | 赛诺医疗 | -7.97% | -1.63% | 4.3分 |
| 86 | 西山科技 | -8.09% | -1.24% | 3.9分 |
| 88 | 奥精医疗 | -8.16% | 2.37% | 3.8分 |
| 90 | 安旭生物 | -8.51% | -0.92% | 4.0分 |
| 92 | 利德曼 | -8.62% | -3.99% | 3.5分 |
| 94 | 睿昂基因 | -8.77% | -1.44% | 4.2分 |
| 96 | 三友医疗 | -8.86% | 0.33% | 4.6分 |
| 98 | 安图生物 | -8.91% | -1.11% | 4.1分 |
| 100 | 采纳股份 | -9.23% | 4.07% | 4.2分 |
| 102 | 心脉医疗 | -9.40% | -0.79% | 4.0分 |
| 104 | 奥美医疗 | -9.47% | -1.56% | 4.8分 |
| 106 | 博拓生物 | -9.66% | 0.05% | 3.9分 |
| 108 | 安必平 | -10.07% | -2.31% | 3.4分 |
| 110 | 祥生医疗 | -10.19% | -1.81% | 4.1分 |
| 112 | 欧普康视 | -10.27% | -1.79% | 4.2分 |
| 114 | 海尔生物 | -10.46% | -1.49% | 4.2分 |
| 116 | 开立医疗 | -10.90% | -1.18% | 4.1分 |
| 118 | 天智航 | -11.22% | -0.33% | 4.3分 |
| 120 | 春立医疗 | -11.92% | -1.85% | 4.5分 |
| 122 | 圣湘生物 | -12.55% | -6.01% | 4.1分 |
| 124 | 康为世纪 | -13.11% | -5.18% | 3.5分 |
| 126 | - | -14.07% | -4.46% | 分 |
| 128 | 楚天科技 | -15.49% | -2.04% | 4.0分 |
| 130 | - | -16.62% | -1.69% | 分 |
| 132 | - | -17.03% | -4.04% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 84/245 ， 107/245。
[{"date":"2025-09-30","value":"1.68","vol":"2.86"},{"date":"2025-06-30","value":"0.59","vol":"2.27"},{"date":"2025-03-31","value":"0.26","vol":"1.15"},{"date":"2024-12-31","value":"2.47","vol":"0.53"},{"date":"2024-09-30","value":"1.94","vol":"4.71"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.68 | 0.59 | 0.26 | 2.47 | 1.94 |
| 行业(%) | 2.86 | 2.27 | 1.15 | 0.53 | 4.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"30.85","vol":"51.79"},{"date":"2025-06-30","value":"28.92","vol":"52.10"},{"date":"2025-03-31","value":"24.45","vol":"51.81"},{"date":"2024-12-31","value":"29.25","vol":"52.63"},{"date":"2024-09-30","value":"29.49","vol":"53.49"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
30.85 | 28.92 | 24.45 | 29.25 | 29.49 |
| 行业(%) | 51.79 | 52.10 | 51.81 | 52.63 | 53.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 36/245 ， 69/245。
[{"date":"2025-09-30","value":"6.14","vol":"-0.61"},{"date":"2025-06-30","value":"6.01","vol":"-1.71"},{"date":"2025-03-31","value":"2.58","vol":"-0.92"},{"date":"2024-12-31","value":"-11.19","vol":"0.64"},{"date":"2024-09-30","value":"-19.32","vol":"0.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.14 | 6.01 | 2.58 | -11.19 | -19.32 |
| 行业(%) | -0.61 | -1.71 | -0.92 | 0.64 | 0.79 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-13.86","vol":"-18.69"},{"date":"2025-06-30","value":"-59.71","vol":"-20.27"},{"date":"2025-03-31","value":"-68.87","vol":"-4.25"},{"date":"2024-12-31","value":"-67.66","vol":"-24.11"},{"date":"2024-09-30","value":"-73.82","vol":"-20.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-13.86 | -59.71 | -68.87 | -67.66 | -73.82 |
| 行业(%) | -18.69 | -20.27 | -4.25 | -24.11 | -20.23 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 47/245 ， 109/245。
[{"date":"2025-09-30","value":"0.28","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.09","vol":"0.08"},{"date":"2024-12-31","value":"0.39","vol":"0.35"},{"date":"2024-09-30","value":"0.27","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.18 | 0.09 | 0.39 | 0.27 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.35 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.77","vol":"1.67"},{"date":"2025-06-30","value":"0.52","vol":"1.13"},{"date":"2025-03-31","value":"0.26","vol":"0.55"},{"date":"2024-12-31","value":"1.03","vol":"2.33"},{"date":"2024-09-30","value":"0.69","vol":"1.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.77 | 0.52 | 0.26 | 1.03 | 0.69 |
| 行业(次) | 1.67 | 1.13 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"3.71","vol":"14.91"},{"date":"2025-06-30","value":"22.10","vol":"15.06"},{"date":"2025-03-31","value":"-0.79","vol":"4.01"},{"date":"2024-12-31","value":"29.74","vol":"29.57"},{"date":"2024-09-30","value":"19.73","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.71 | 22.10 | -0.79 | 29.74 | 19.73 |
| 行业 | 14.91 | 15.06 | 4.01 | 29.57 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.18","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.95","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.18 | - | 3.95 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.19 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/245 ， 7/245。
[{"date":"2025-09-30","value":"2.01","vol":"5.68"},{"date":"2025-06-30","value":"2.01","vol":"5.50"},{"date":"2025-03-31","value":"2.07","vol":"5.89"},{"date":"2024-12-31","value":"1.99","vol":"5.34"},{"date":"2024-09-30","value":"2.03","vol":"5.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.01 | 2.01 | 2.07 | 1.99 | 2.03 |
| 行业 | 5.68 | 5.50 | 5.89 | 5.34 | 5.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.15","vol":"4.56"},{"date":"2025-06-30","value":"1.09","vol":"4.40"},{"date":"2025-03-31","value":"1.11","vol":"4.77"},{"date":"2024-12-31","value":"1.05","vol":"4.32"},{"date":"2024-09-30","value":"1.07","vol":"4.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.15 | 1.09 | 1.11 | 1.05 | 1.07 |
| 行业 | 4.56 | 4.40 | 4.77 | 4.32 | 4.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 10/245 ， 14/245。
[{"date":"2025-09-30","value":"39.19","vol":"22.06"},{"date":"2025-06-30","value":"39.36","vol":"22.01"},{"date":"2025-03-31","value":"38.09","vol":"21.24"},{"date":"2024-12-31","value":"38.43","vol":"21.92"},{"date":"2024-09-30","value":"38.44","vol":"20.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.19 | 39.36 | 38.09 | 38.43 | 38.44 |
| 行业(%) | 22.06 | 22.01 | 21.24 | 21.92 | 20.92 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.66","vol":"0.72"},{"date":"2025-06-30","value":"0.67","vol":"0.58"},{"date":"2025-03-31","value":"0.63","vol":"0.57"},{"date":"2024-12-31","value":"0.64","vol":"0.55"},{"date":"2024-09-30","value":"0.64","vol":"0.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.66 | 0.67 | 0.63 | 0.64 | 0.64 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"8.28","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.18","blueLineValue":"0.15","type":"YC"}]